Ukrainian pharma company eyes to launch production in Uzbekistan

Business Materials 11 September 2021 13:30 (UTC +04:00)
Ukrainian pharma company eyes to launch production in Uzbekistan

BAKU, Azerbaijan, Sept. 11

By Fakhri Vakilov - Trend:

Ukrainian "Lekhim" pharmaceutical company Lekhim expects to launch the first stage of production in Uzbekistan in 2023, Trend reports citing Ukranian media.

The company opened an Uzbek office last year. According to the chairman of the supervisory board Valery Pechaev, the main task was to find a place for production.

For the construction of the plant, a plot of 3 hectares was selected on the outskirts of Tashkent. After completing all the necessary documents, construction began this spring.

Pechaev added that Lekhim has already invested $2.5 million, and will invest $10-12 million for the launch of the first stage. He estimated the total cost of the plan at $40 million. The company intends to attract about 30 percent of funds from the European Bank for Reconstruction and development.

The first stage involves production of injectable drugs, as well as the construction of an administrative building, a main laboratory and a workshop for the production of electricity. The production will be launched on an area of ​​4,500 sq. m. and will include an injection line for 50 million ampoules per year. In the future, there will be three such lines.

In addition, the future plant will have capacities for the production of cephalosporin antibiotics (15-20 million bottles per year), as well as the production of drugs in the form of tablets (up to 1 billion pieces annually). Construction work will begin in 2024.

The plant will produce drugs worth $60 million a year, mainly for Uzbekistan and other Central Asian countries. Also, the goods will be exported to Afghanistan.


Follow author on Twitter: @vakilovfaxri